Jim Dillon

Mr. Dillon is the President & CEO of BioVentrix, an innovative company focused on improving treatment for heart failure. He started at St. Jude Medical in 2011 and has held a series of increasingly responsible corporate strategy and sales leadership positions. Within these roles, he drove market development and new technology adoption, executed capital/consumable sales strategies, and built high-performance elite commercial teams focused on the sales and marketing of complex and innovative medical devices. Dillon was also involved with multiple highly successful medical device companies including startups VNUS Medical Technologies, Perclose, Heart Technologies, and Devices for Vascular Intervention as a key contributor to their acquisition and exit, as well as providing prominent leadership related to both sales and business development. Prior to joining St. Jude, he also held senior executive sales and marketing positions with such companies as Abiomed, TherOx, and InfraRe Dx, where he was intimately involved with global clinical development and commercial distribution.